You are here

  • Home
  • Archive
  • Volume 29, Issue Suppl 3
  • 120 Factors associated with extended survival for patients with platinum-resistant ovarian cancer (PROC) treated with modified vaccinia oncolytic virotherapy (VOV)

Citation Tools

Article menu

Download PDFPDF

E-Poster viewings
19–21 September
Basic – Translational science
IGCS19-0687
120 Factors associated with extended survival for patients with platinum-resistant ovarian cancer (PROC) treated with modified vaccinia oncolytic virotherapy (VOV)
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Manyam M, Stephens A, Kennard J, et al
120 Factors associated with extended survival for patients with platinum-resistant ovarian cancer (PROC) treated with modified vaccinia oncolytic virotherapy (VOV)
International Journal of Gynecologic Cancer 2019;29:A58.